Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8018493rdf:typepubmed:Citationlld:pubmed
pubmed-article:8018493lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:8018493lifeskim:mentionsumls-concept:C0034150lld:lifeskim
pubmed-article:8018493lifeskim:mentionsumls-concept:C0020846lld:lifeskim
pubmed-article:8018493lifeskim:mentionsumls-concept:C0450254lld:lifeskim
pubmed-article:8018493pubmed:issue2lld:pubmed
pubmed-article:8018493pubmed:dateCreated1994-8-1lld:pubmed
pubmed-article:8018493pubmed:abstractTextThe incidences of clinical and biological markers of atopy were investigated in 16 children with IgA nephropathy (IgAN) (group A) and in 22 with Henoch-Schönlein purpura nephritis (HSPN) (group B). The incidence of increased plasma IgE levels according to age-matched normal values was significantly higher in group B (17/22, 77%) than in group A (7/16, 44%) (P < 0.05). Although not significant, the incidences of positive RAST tests and of a history of typical atopic symptoms were also higher in group B [10/22 (45%) and 11/22 (50%), respectively] than in group A [4/16 (25%) and 5/16 (31%), respectively]. Moreover, IgE deposits were demonstrated by a peroxidase/anti-peroxidase method on cutaneous Langerhans and mast cells in 4 of 6 patients with HSPN. Thus immunoallergy might account, in some cases, for the cutaneous, intestinal and pulmonary signs observed in HSPN, but not in IgAN. We postulate stimulation of IgE-sensitized mast cells by specific antigens in the presence of IgA circulating immune complexes (CIC), release of vasoactive substances, increased capillary permeability and perivascular deposition of IgA CIC.lld:pubmed
pubmed-article:8018493pubmed:languageenglld:pubmed
pubmed-article:8018493pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018493pubmed:citationSubsetIMlld:pubmed
pubmed-article:8018493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018493pubmed:statusMEDLINElld:pubmed
pubmed-article:8018493pubmed:monthAprlld:pubmed
pubmed-article:8018493pubmed:issn0931-041Xlld:pubmed
pubmed-article:8018493pubmed:authorpubmed-author:GrossmanDDlld:pubmed
pubmed-article:8018493pubmed:authorpubmed-author:NagyJJlld:pubmed
pubmed-article:8018493pubmed:authorpubmed-author:HallMMlld:pubmed
pubmed-article:8018493pubmed:authorpubmed-author:ChantraineJ...lld:pubmed
pubmed-article:8018493pubmed:authorpubmed-author:DechenneCClld:pubmed
pubmed-article:8018493pubmed:authorpubmed-author:DavinJ CJClld:pubmed
pubmed-article:8018493pubmed:authorpubmed-author:PierardGGlld:pubmed
pubmed-article:8018493pubmed:authorpubmed-author:JansenFFlld:pubmed
pubmed-article:8018493pubmed:authorpubmed-author:MalaiseMMlld:pubmed
pubmed-article:8018493pubmed:authorpubmed-author:QuacoeMMlld:pubmed
pubmed-article:8018493pubmed:issnTypePrintlld:pubmed
pubmed-article:8018493pubmed:volume8lld:pubmed
pubmed-article:8018493pubmed:ownerNLMlld:pubmed
pubmed-article:8018493pubmed:authorsCompleteNlld:pubmed
pubmed-article:8018493pubmed:pagination169-71lld:pubmed
pubmed-article:8018493pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8018493pubmed:meshHeadingpubmed-meshheading:8018493-...lld:pubmed
pubmed-article:8018493pubmed:meshHeadingpubmed-meshheading:8018493-...lld:pubmed
pubmed-article:8018493pubmed:meshHeadingpubmed-meshheading:8018493-...lld:pubmed
pubmed-article:8018493pubmed:meshHeadingpubmed-meshheading:8018493-...lld:pubmed
pubmed-article:8018493pubmed:meshHeadingpubmed-meshheading:8018493-...lld:pubmed
pubmed-article:8018493pubmed:meshHeadingpubmed-meshheading:8018493-...lld:pubmed
pubmed-article:8018493pubmed:meshHeadingpubmed-meshheading:8018493-...lld:pubmed
pubmed-article:8018493pubmed:meshHeadingpubmed-meshheading:8018493-...lld:pubmed
pubmed-article:8018493pubmed:meshHeadingpubmed-meshheading:8018493-...lld:pubmed
pubmed-article:8018493pubmed:meshHeadingpubmed-meshheading:8018493-...lld:pubmed
pubmed-article:8018493pubmed:meshHeadingpubmed-meshheading:8018493-...lld:pubmed
pubmed-article:8018493pubmed:meshHeadingpubmed-meshheading:8018493-...lld:pubmed
pubmed-article:8018493pubmed:meshHeadingpubmed-meshheading:8018493-...lld:pubmed
pubmed-article:8018493pubmed:meshHeadingpubmed-meshheading:8018493-...lld:pubmed
pubmed-article:8018493pubmed:year1994lld:pubmed
pubmed-article:8018493pubmed:articleTitlePossible pathogenic role of IgE in Henoch-Schönlein purpura.lld:pubmed
pubmed-article:8018493pubmed:affiliationPaediatric Nephrology Unit, State University of Liège, Belgium.lld:pubmed
pubmed-article:8018493pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8018493pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8018493lld:pubmed